Providers must redefine cancer CI policies following breakthrough treatment
Critical illness (CI) policyholders may not be able to claim for skin cancer soon after a recent breakthrough could render the disease curable and no longer critical. Insurers will have to look at the definitions within CI relating to cancer following a groundbreaking development. Last month, a cure for skin cancer came a step closer to fruition after American researchers took cancer-fighting immune cells, made five billion copies, then put them back into a man riddled with the disease. After this had been done, scans showed the tumours had disappeared and after two years he remained ...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes